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Abstract: A minimal model system for membrane fusion, comprising two complementary peptides
dubbed “E” and “K” joined to a cholesterol anchor via a polyethyleneglycol spacer, has previously
been developed in our group. This system promotes the fusion of large unilamellar vesicles and
facilitates liposome-cell fusion both in vitro and in vivo. Whilst several aspects of the system have
previously been investigated to provide an insight as to how fusion is facilitated, anchor positioning
has not yet been considered. In this study, the effects of placing the anchor at either the N-terminus or
in the center of the peptide are investigated using a combination of circular dichroism spectroscopy,
dynamic light scattering, and fluorescence assays. It was discovered that anchoring the “K” peptide
in the center of the sequence had no effect on its structure, its ability to interact with membranes,
or its ability to promote fusion, whereas anchoring the ‘E’ peptide in the middle of the sequence
dramatically decreases fusion efficiency. We postulate that anchoring the ‘E’ peptide in the middle of
the sequence disrupts its ability to form homodimers with peptides on the same membrane, leading
to aggregation and content leakage.
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1. Introduction
Within cells, the process of membrane fusion regulates a range of vital processes, including
intracellular transport and exocytosis. In eukaryotic cells, these fusion events are regulated by a
family of proteins named soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein receptor
(SNARE) proteins [1–4].
One specific SNARE-mediated membrane fusion process that has been widely studied in recent
years is that of neurotransmitter release; neurotransmitters are packaged into vesicles functionalized
with one SNARE protein and this interacts with two other SNARE proteins associated with the axonal
presynaptic membrane to release neurotransmitters into the synaptic cleft [5,6]. This fusion process
has four main steps: initially, the vesicle and axonal membranes are bought into close proximity by
the three SNARE proteins from both membranes interacting to form a tetrameric coiled-coil; secondly,
localized disruption of the membranes occurs; in the third step, the lipids of the outer membranes
mix in a process known as hemifusion; and finally, the inner membranes mix and the contents are
transferred [7].
Using the natural SNARE proteins to study membrane fusion processes is clearly the most
accurate way to understand more about these mechanisms, but, due to the number of proteins
involved, it is often difficult to isolate the roles of specific proteins [8], and some studies involving
reconstituted SNAREs have failed to lead to fusion [9]. Developing model systems for membrane
fusion may therefore be a solution to some of these issues, and in addition to providing fundamental
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mechanistic insights, model systems may also have applications as, for example, drug delivery systems.
Numerous model systems have been developed in recent years with a range of molecules, such as
deoxyribonucleic acid (DNA) [10–13], peptide nucleic acid (PNA) [14,15], peptides [16–19], and other
small-molecule recognition complexes being employed as fusogens [20–23].
In our lab, we have developed a model system for membrane fusion which comprises two
complementary coiled-coil-forming peptides known as peptide E and peptide K. These peptides are
named due the prevalence of glutamic acid (E) residues in peptide E (EIAALEK)n and lysines (K) in
peptide K (KIAALKE)n [24,25]. These peptides are linked to a cholesterol anchor via a polyethylene
glycol (PEG) spacer, generating lipidated constructs dubbed CPE and CPK. This cholesterol anchors
the peptides into liposomal membranes, and it has been previously demonstrated that, when
CPE- and CPK-functionalized liposome populations are mixed, efficient and leakage-free lipid- and
content-mixing occurs (Scheme 1) [18]. We have previously probed numerous aspects of this system,
including the peptide length and orientation [26,27], the PEG length [28], and the anchor type [29].
Another study examined the effect of placing the anchor at the C- or N-terminus of the peptide or
at both ends to generate a doubly anchored construct. It was discovered that the end at which the
peptide was anchored, or indeed the presence of two anchors, did not affect either the rate or the extent
of fusion [30].
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residues found in the center of the protein sequence [32,33]. It would therefore be interesting to 
modify the E and K peptides so that the anchor is found at the center of the sequence and to compare 
these constructs to those which are anchored via the N-termini to determine which is the more 
effective anchor position. 
This system was probed using a combination of circular dichroism (CD) spectroscopy, lipid- and 
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Scheme 1. A peptide-mediated model system for membrane fusion. (Left): E (red) and K (blue)
peptides are incorporated into liposomes; the E peptides are either unfolded or form homodimers,
and the K peptides interact with lipid membranes [31]. Upon mixing the two liposome populations,
(middle), coiled-coil heterodimers are formed between the two peptides; this brings the membranes
into close proximity, which facilitates full fusion, also known as content mixing (right).
In this study, we aim o prob the question of anch r positioning further by examining the effect
of placing the anchor in the center f the peptide. This is of interest as the majority of SNARE proteins
are held in membranes by hydrophobic transmembrane domains, but some SNARE proteins, such an
SNAP-25, are tethered to the membrane via palmitoyl side-chains that are bound to cysteine residues
found in the center of the protein sequence [32,33]. It would therefore be interesting to modify the
E and K peptides so that the anchor is found at the center of the sequence and to compare these
constructs to those which are anchored via the N-termini to determine which is the more effective
anchor position.
This system was probed using a combination of circular dichroism (CD) spectroscopy, lipid- and
content-mixing fluorescence assays, tryptophan fluorescence studies, and dynamic light scattering
(DLS) to determine the effects of anchor positioning on peptide structure and both the rate and extent
of membrane fusion.
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It was discovered that placing the anchor in the center of the peptide sequence did not have a large
effect on the structure of peptide K, but decreased the helicity of peptide E, although both peptides
retained the ability to form a coiled-coil upon addition of the complementary peptide. Fusion was
not affected when peptide K was anchored centrally, but strongly reduced lipid- and content-mixing
was observed when the E peptide was anchored in this position. An increase in content leakage and a
change in liposome size over time was also observed with this construct. It is postulated that anchoring
the E peptide in the center of the sequence prevents homodimer formation with other peptides on
the same liposome, leading to aggregation as homodimers are formed with peptides on neighboring
liposomes. This aggregation then causes the liposomes to become unstable and limits the ability of this
system to effectively facilitate lipid- and content-mixing.
2. Results
2.1. Design of the Study
Inspired by the way in which some SNARE proteins, such as SNAP-25, are anchored to
membranes [32,33], we decided to modify our model system to generate peptide constructs which
had lipid anchors in the center of the peptide sequences. To facilitate this, the glutamic acid found at
the ‘f’ position of the second heptad of the K peptide was mutated to lysine (Figure 1). A lysine was
already found at this position in the E peptide, so no sequence modification was necessary. To enable
anchor attachment, the highly acid labile methoxytrityl (mtt) protecting group was used to protect the
lysine at this position. Upon completion of the peptide synthesis, this mtt group could be selectively
deprotected to allow the PEG linker and cholesteryl anchor to be attached to the terminal amine group
of this lysine side-chain, generating constructs named fCPE and fCPK, to reflect the position of anchor
attachment (Figure 1A). The consequence of anchoring the peptide at this position is an increased
overall charge, from +4 to +5 for the K peptide and from −4 to −5 for the E peptide. To test whether
this increased charge would affect fusion, two control peptide constructs were synthesized which also
possessed mtt-protected lysine in this position, but in this case the lysine side-chain was acetylated
after synthesis to produce the control constructs AcCPE and AcCPK (Figure 1B), which possessed the
same charge as the fCPE and fCPK peptides.
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All four constructs were incorporated into liposomes and their secondary structures probed 
using CD spectroscopy. It is known that tethering peptides to a lipid surface can influence their 
secondary structure, particularly in the case of peptide K, which is required to interact with liposomes 
in order to facilitate fusion [31,34]. 
As is evident from Figure 2A, both fCPK and AcCPK exhibit similar CD spectra, which show a 
partial helical character when tethered to liposomes; this is consistent with previous observations for 
CPK [31]. Upon adding an equimolar amount of the complementary E peptide, the peak at 222 nm 
intensifies and the ratio between 208/222 nm is close to 1 (Table 1), which is indicative of coiled-coil 
Figure 1. Structures of the cholesterol-anchored peptide constructs used in this study. (A) The structures
of fCPK (top) and fCPE (bottom); (B) the structures of AcCPK (top) and AcCPE (bottom).
2.2. CD Spectroscopy
All four constructs were incorporated into liposomes and their secondary structures probed using
CD spectroscopy. It is known that tethering peptides to a lipid surface can influence their secondary
structure, particularly in the case of peptide K, which is required to interact with liposomes in order to
facilitate fusion [31,34].
As is evident from Figure 2A, both fCPK and AcCPK exhibit similar CD spectra, which show a
partial helical character when tethered to liposomes; this is consistent with previous observations for
CPK [31]. Upon adding an equimolar amount of the complementary E pepti e, th peak at 222 nm
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intensifies and the ratio between 208/222 nm is close to 1 (Table 1), which is indicative of coiled-coil
formation. The differences in spectral shape and intensity between the two samples (fCPK + E and
AcCPK + E) are negligible, indicating that anchor position does not affect the ability of the K peptide
to form a coiled-coil with the E peptide.
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Figure 2. Circular dichroism ( spectra of the peptide constru ts incorporated into liposomes.
(A) c (red solid line) and fCPK (blue solid line) show comparable partial helicity when
incorporated into liposomes, and upon addition of E, coiled-coil species are observed with both
AcCPK (red dotted line) and fCPK (blue dotted line); (B) AcCPE (red solid line) and fCPE (blue solid
line) are largely unfolded when incorporated into liposomes, but form coiled-coils upon K addition
(red and blue dotted lines). (Total lipid) = 0.25 mM with 1 mol % cholesterol-anchored peptide and one
equivalent E or K where stated, phosphate buffered saline (PBS), pH 7.4.
I contrast, the spectra for fCPE and AcCPE, while similar n hape, how significant differences
in intensity (Figure 2B). These spectra indicate that these peptides are also partially folded as α-helices,
and previous work reveals that this partial helicity originates from homomeric interactions between
the E-peptides on the liposome surface [28,31,34]. These spectra may therefore indicate that the ability
of the fCPE peptide to form these homomeric interactions is greatly reduced. Upon the addition of
peptide K to both AcCPE and fCPE, more helical species are observed, indicating both peptides form
heteromeric coiled-coils with peptide K.
Table 1. Molar ellipticities and helicity information for the peptides used in this study.
Peptides (θ)222nm(deg cm2 dmol.res−1) % α-helix
a (θ)222nm/(θ)208nm
f-CPE −9786 30% 0.42
f-CPE + K −18,705 55% 0.84
Ac-CPE −19,986 58% 0.64
Ac-CPE + −26,167 75% 0.89
f-CPK −17,112 50% 0.75
f-CPK + E −21,600 63% 0.94
Ac-CPK −13,017 39% 0.62
Ac-CPK + E −19,940 58% 0.87
a Percentage helicity was calculated from the molar ellipticity at 222 nm using previously reported methods [35].
Collectively, these data indicate that the anchor osition does n t affect the s condary structure of
the K-variants, but that the ability of the E peptide to f rm homomeric int ractio may be disrupted
when the anchor is placed in a central position. Whilst s me of these intensity differences may result
from concentration errors, as these peptides do not contain chromophores, the differences are too large
to arise solely from such errors. Importantly, these data show that all of the constructs are still able to
form coiled-coils effectively when the complementary peptide is added, and the spectra are similar to
those observed when E and K are examined in the absence of liposomes (Figure S1). As coiled-coil
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formation is critical for liposome fusion these data indicate that, structurally, all of these constructs
should be capable of promoting fusion.
2.3. Lipid Mixing
To determine whether fCPE and fCPK were capable of promoting lipid-mixing, an intermediate step
in the fusion process, a Förster resonance energy transfer (FRET) assay was performed. To facilitate this,
0.5 mol % of both 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl)
(DOPE-LR) and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2,1,3-benzoxadiazol-4-yl)
(DOPE-NBD) were incorporated into liposomes containing fCPK or AcCPK. When ~100 nm liposomes
are formed, the distance between the NBD and LR fluorophores is sufficiently small that FRET occurs
between the two. Upon lipid-mixing, this distance increases and FRET no longer occurs, so the
emission of the NBD fluorophore can be measured and if an increase in the intensity of the emission
occurs this is indicative of lipid-mixing.
Figure 3A shows a representative experiment that monitors the increase in fluorescence intensity
over 1 h for the fCPK and fCPE pairing, the control peptides, and mixed combinations. From this
data, it can be concluded that the AcCPE and AcCPK pairing is most efficient at lipid-mixing, with
35% lipid-mixing being observed after one hour. If one of these peptides is swapped for the centrally
anchored derivative, a small decrease in lipid-mixing is observed. This decrease is negligible for
the AcCPE and fCPK pairing, whereas a slightly larger decrease is observed for the AcCPK-fCPE
pairing. It should be noted, however, that the extent of lipid-mixing is highly variable for this pairing
(Figure 3B). All three of these combinations exhibit comparable initial rates of lipid-mixing, indicating
that substituting one of the N-terminally linked peptides for a centrally anchored variant has only a
small effect on the efficiency of the hemifusion process.
When both fCPE and fCPK are employed, however, a significant drop in both the rate and
extent of lipid-mixing is observed, meaning that only small amounts of lipid-mixing occur when both
centrally-anchored peptide contructs are employed.
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(green); and fCPK–AcCPE (orange). Error bars indicate the standard error of measurement between 
four samples. (B) Average and standard deviation of the total % of lipid-mixing for three independent 
sets of experiments with: AcCPK–AcCPE (blue); fCPK–fCPE (red); AcCPK–fCPE (green); and fCPK–
AcCPE (orange). (Total lipid) = 100 µM of DOPC:DOPE:Cholesterol, 50:25:25 mol %, with 1 mol % 
cholesterol-anchored peptide, PBS, pH 7.4. 
Figure 3. Lipid-mixing experiments for all combinations of fCPK, fCPE, AcCPK, and AcCPE.
(A) Representative lipid-mixing plots for: AcCPK–AcCPE (blue); fCPK–fCPE (red); AcCPK–fCPE
(green); and fCPK–AcCPE (orange). Error bars indicate the standard error of measurement between
four samples. (B) Average and standard deviation of the total % of lipid-mixing for three independent
sets of experiments with: AcCPK–AcCPE (blue); fCPK–fCPE (red); AcCPK–fCPE (green); and
fCPK–AcCPE (orange). (Total lipid) = 100 µM of DOPC:DOPE:Cholesterol, 50:25:25 mol %, with
1 mol % cholesterol-anchored peptide, PBS, pH 7.4.
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2.4. Content-Mixing
As lipid-mixing, or hemifusion, is an intermediate step in the full fusion (content-mixing) process,
it is unlikely that the fCPE–fCPK pairing will efficiently promote content-mixing, as only low levels of
lipid-mixing were observed, but this was still probed. Liposomes bearing fCPE or AcCPE were loaded
with a self-quenching concentration of sulforhodamine B. If content-mixing with CPK-functionalised
liposomes occurs, the sulforhodamine B will dilute below its self-quenching concentration and an
increase in fluorescence will be observed.
Figure 4 shows that the AcCPK–AcCPE pairing is capable of promoting content-mixing with
no leakage (Figure S2). After one hour, 60% content-mixing is achieved, which is comparable to the
amount of content-mixing facilitated by the CPE and CPK peptides used in previous studies [27,29].
The AcCPE–fCPK pairing also facilitates efficient content-mixing; both the rate and extent of mixing
are comparable to the AcCPE–AcCPK pairing.
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The fact that both AcCPK and fCPK promote content-mixing when mixed with AcCPE is 
consistent with the CD data, which showed that both AcCPK and fCPK adopted partially helical 
structures when incorporated into liposomes and formed coiled-coils when the complementary E-
peptide was added. This coiled-coil formation is the first step in the fusion process, and it is also 
important that the K-peptides are helical on liposomal membranes as their interaction with the 
liposome membranes is critical for fusion in this model system. To confirm that fCPK and AcCPK 
still interact with membranes, as the CD and content-mixing data suggest, variants bearing a 
tryptophan (trp) residue at their C-terminus were synthesized. Tryptophan fluorescence experiments 
were subsequently performed with these constructs at different peptide to lipid ratios, and these 
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Figure 4. Content-mixing experiments for all combinations of fCPK, fCPE, AcCPK, and AcCPE.
Representative content-mixing plots for: (A) AcCPE–AcCPK (blue) and AcCPE–fCPK (orange);
(B) fCPE–fCPK (red) and fCPE–AcCPK (green). Zero percent controls represent samples of E-labeled
liposomes mixed with plain liposomes. (Total lipid) = 100 µM of DOPC:DOPE:Cholesterol, 50:25:25
mol %, with 1 mol % cholesterol-anchored peptide, PBS, pH 7.4.
The fact that both AcCPK and fCPK promote content-mixing when mixed with AcCPE is
consistent with the CD data, which showed that both AcCPK and fCPK adopted partially helical
structures when incorporated into liposomes and formed coiled-coils when the complementary
E-peptide was added. This coiled-coil formation is the first step in the fusion process, and it is
also important that the K-peptides are helical on liposomal membranes as their interaction with
the liposome membranes is critical for fusion in this model system. To confirm that fCPK and
AcCPK still interact with membranes, as the CD and content-mixing data suggest, variants bearing a
tryptophan (trp) residue at their C-terminus were synthesized. Tryptophan fluorescence experiments
were subsequently performed with these constructs at different peptide to lipid ratios, and these
showed an increase in the intensity of the trp emission as the liposome concentration was increased
(Figure 5A). A blue shift of the spectrum was also observed. Taken together, this fluorescence increase
and the accompanying blue shift indicate that the trp residue is in a more hydrophobic environment
when liposomes are present [36,37], suggesting that the peptide interacts with the liposomes. This has
been observed for the original CPK variant [34,38], indicating that altering the charge of the peptide,
for the AcCPK construct, coupled with changing the anchor position for fCPK, does not affect the
ability of the peptide to interact with the liposome membrane.
When the fCPE construct is employed, it appears that content-mixing is observed for both the
fCPE–fCPK and fCPE–AcCPK pairings, but when the 0% control is studied, a significant increase
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of fluorescence is also observed, indicating leakage of the dye from the fCPE liposomes (Figure 4B).
The initial rate of leakage is different to the initial rate observed when fCPE is mixed with either
fCPK or AcCPK, suggesting that some content-mixing may occur at first, but the final change in
fluorescence for both samples with fCPE is 18% less than with the samples containing AcCPE. When
leakage is accounted for (Figure S2), a relative fluorescence increase of only 17% for samples with
fCPE, compared to 64% for samples with AcCPE, is observed. These figures suggest that a small
amount of content-mixing seems to occur with the fCPE liposomes, but this fluorescence assay cannot
differentiate adequately between content-mixing and leaking, therefore it is not possible to draw firm
conclusions about whether content-mixing is occurring when the fCPE variant is employed.
2.5. Size Increase Studies
To probe this unusual behavior of fCPE further, dynamic light scattering (DLS) was employed
to study the stability of the liposomes over time. Size changes of liposomes functionalized with both
AcCPE and fCPE were investigated, and one equivalent of the complementary K peptide was added to
fCPE-functionalized liposomes in another experiment. It is evident from Figure 5B that no significant
size increase is observed for the AcCPE-functionalized liposomes, whereas the fCPE-functionalized
liposomes increase in diameter from 100 nm to over 400 nm in 90 min. This change in size is
accompanied by a significant change in the polydispersity of the sample, which is indicative of
aggregate formation. When an equivalent of the K peptide is added to these liposomes, no size increase
is observed over the same time period. Taken together, these data indicate that the size increase is likely
to be due to homodimer formation between peptides anchored in different liposomes. The absence of
a size increase when the K peptide is added is likely to be because EK heterodimers are formed, which
are more stable than homodimers, and so the fCPE-functionalized liposomes are stabilized.
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Figure 5. (A) Liposome-dependent tryptophan fluorescence spectra for fCPK peptide constructs
(dotted lines) and AcCPK variants (solid lines) with a glycine and tryptophan on the C-terminus.
Peptide concentration was kept constant at 2.5 µM, and the amount of lipids was varied to
create liposomes with three different peptide fractions: 5% (blue), 1 % (red), and 0.25% (green).
(B) Lipsome size increase monitored by dynamic light scattering (DLS). Size increase over 90 min for:
fCPE-functionalized liposomes (blue); fCPE-functionalized liposomes with one equivalent of peptide
K (red); and AcCPE-functionalized liposomes (green). Error bars indicate the 95% size distribution.
(Total liposome) = 0.5 mM, PBS, pH 7.4.
3. Discussion
We have demonstrated that changing the position of the cholesterol anchor site from the
N-terminus to the center of the peptide affects E and K differently. CD spectroscopy demonstrates
that both AcCPK and fCPK can interact with membranes; this is corroborated by an increase in
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trpfluorescence that is observed when trp-labelled derivatives of these constructs are mixed with
liposomes. CD spectroscopy also revealed that both K constructs form coiled-coils when E is added.
It has been demonstrated previously that both K-membrane interactions and EK-heterodimer formation
are critical for effective fusion [28,34,38], so the fact that altering the anchor position has no effect
suggests that these constructs should still be capable of promoting fusion. This is demonstrated
to be the case, with both AcCPK and fCPK facilitating lipid- and content-mixing when combined
with AcCPE.
Different behavior is observed for the AcCPE and fCPE derivatives. While AcCPE can promote
leakage-free lipid- and content-mixing, reduced amounts of lipid-mixing are observed when the fCPE
construct is employed, and significant leakage is observed during content-mixing when the fCPE
construct is combined with either AcCPK or fCPK. An insight into what may be occurring is provided
by the dynamic light scattering experiments, which show that the average particle size in a solution of
fCPE-functionalized liposomes increases from 100 nm to 400 nm after 90 min. Previous studies of this
system have shown that, in the absence of K, the E peptide exists primarily as a weakly associated
homodimer on the surface of liposomes [31]. We postulate that, by anchoring the E peptide in the
middle of the sequence, it is sterically prevented from forming homodimers with other peptides
anchored in the same liposome. Homodimers therefore result from peptides on different liposomes
interacting with each other, which leads to aggregation. This aggregation may subsequently lead to
the destabilization of the liposomes, triggering content leakage, which is a phenomenon that has been
observed in other peptide- and DNA-mediated fusion systems [16,39–41].
This hypothesis that f-position anchoring decreases homomeric interactions could also explain the
significantly lower lipid-mixing for the fCPE–fCPK combination in comparison to fCPE–AcCPK. In our
liposomal fusion model system, coiled-coil formation is the first step of the fusion process; this brings
the membranes in close proximity but the peptides are still able to dissociate, which allows peptide
K to interact with opposing liposomal membranes and promote complete fusion [38]. Changing
the anchoring position may have a significant influence on the equilibrium between associated and
dissociated E and K peptides, because there is a larger thermodynamic penalty for CPE to dissociate
since it cannot form a stable homodimer. At the same time, changing the lipid attachment to form
fCPK could disfavor the dissociation path where peptide K enters the membrane of the liposome that
it is attached to, lowering the total amount of membrane-interacting peptide further.
Future studies could focus on probing this hypothesis further: AcCPE and fCPE constructs could
be incorporated into the same liposome to determine whether homodimer formation is possible
between the alternatively anchored constructs, and if so, this should decrease content leakage.
FRET-pair labeled versions of CPE and CPK could be synthesized to observe the interactions of
these peptides when two different populations of liposomes are mixed. Another possible explanation
for the high levels of content leakage observed could be that the fCPE peptides are interacting with
the liposomes. This is unlikely as the peptide sequence has not been significantly changed, but this
could be probed by synthesizing tryptophan-functionalized derivatives and performing tryptophan
fluorescence experiments in the absence and presence of liposomes.
4. Materials and Methods
4.1. Materials
Tentagel HL-RAM resin was obtained from Rapp Polymere (Tuebingen, Germany).
Fmoc-protected amino acids and O-(1H-6-Cholorobenzotriazol-1-yl)-1,1,3,3-tetramethyluronium
hexafluorophosphate (HCTU) were purchased from NovaBiochem (Amsterdam, The Netherlands).
Acetic anhydride, acetonitrile, dimethylformamide (DMF), dioxane, methanol, piperidine, pyridine,
and trifluoroacetic acid (TFA) were purchased from Biosolve (Valkenswaard, The Netherlands).
N,N-Diisopropylethylamine (DIPEA) and Oxyma were purchased from Carl Roth (Karlsruhe, Germany).
Cholesterol, cholesteryl hemisuccinate, Diisopropylcarbodiimide (DIC), tert-butanol, sulforhodamine B,
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sodium hydroxide, triisopropylsilane (TIPS), and trimethylphosphine (1 M in toluene) were obtained
from Sigma Aldrich (Zwijndrecht, The Netherlands). Chloroform, dichloromethane (DCM), and
diethyl ether were supplied by Honeywell (Meppel, The Netherlands). The compounds 1,2-dioleoyl-
sn-glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE),
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (DOPE-LR), and
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2,1,3-benzoxadiazol-4-yl) (DOPE-NBD)
were all purchased from Avanti Polar Lipids (Alabaster, AL, USA). Ultrapure water was purified using
a Milli-Q™ purification system from Millipore (Amsterdam, The Netherlands).
4.2. N3-PEG4-COOH Synthesis
Ethyl 14-Azido-3,6,9,12-tetraoxatetradecan-1-oate (N3-PEG4-COOEt) was synthesized according
to literature methods [42]. N3-PEG4-COOEt (1.64 g, 5.4 mmol) was dissolved in MeOH (25 mL). NaOH
(1 M, 8 mL) was added, and the reaction was stirred overnight or until thin-layer chromatography
(TLC) indicated complete conversion of the starting material. The reaction was diluted with H2O
(12 mL), and the methanol was evaporated. The aqueous layer was washed with DCM (25 mL),
acidified with HCl, and extracted with DCM (3 × 25 mL). After drying with Na2SO4, the solvent was
removed to yield the product as a viscous liquid in quantitative yield. 1H NMR (300 MHz, CDCl3)
δ 10.80 (s, 1H), 4.07 (s, 2H), 3.64–3.63 (m, 2H), 3.6–3.55 (m, 12H), 3.28 (t, J = 6.0 Hz, 2H). 13C NMR
(300 MHz, CDCl3) δ 173.73, 70.82, 70.35, 70.29, 70.23, 70.17, 69.75, 50.38, (Figure S4).
4.3. Peptide Synthesis
Peptide synthesis was performed using a microwave-assisted Liberty Blue automated synthesizer
from CEM (Matthews, NC, USA). Peptides were synthesized on a 0.1 mmol scale using Tentagel
HL-RAM resin with a loading capacity of 0.37 mmol g−1. Fmoc deprotection was achieved using a
solution of 20% piperidine in DMF under heating at 90 ◦C for 1 min, followed by three washing steps.
Coupling of amino acids was performed using 4 mL of coupling solution, containing 0.125 M of the
respective amino acid, 0.25 M DIC as activator, and 0.125 M oxyma as base. Amino acid coupling was
performed at 90 ◦C for 4 min.
To allow for selective deprotection and modification, mtt-protected lysine was used at position 14
of the peptide sequences. Once synthesis was complete, the peptide was first PEGylated or acylated
on the N-terminus before modification of the mtt-protected lysine. The mtt-protecting group was
selectively removed using DCM containing 3% TFA and 3% TIPS. Aliquots (2 mL) of this solution
were added to the resin, which was shaken for 2 min before being washed with DMF. These steps
were repeated until the yellow colour (indicative of the mtt-protecting group) was no longer observed.
At this point, the peptides were PEGylated, reduced, lipidated, and cleaved as for the N-terminally
anchored peptides.
Peptide PEGylation and lipidation was performed on resin, using two equivalents of the
N3-PEG4-CH2-COOH spacer, HATU (two eq.) and DIPEA (four eq.). The resin was subsequently
washed with DMF, and azide reduction was performed using trimethylphosphine (10 eq.) in 4:1
dioxane:water. After coupling, the resin was washed using 4:1 dioxane:water, DMF, and DCM.
Lipidation was facilitated using cholesteryl hemisuccinate (two eq.) with HATU (two eq.) and DIPEA
(four eq.). All conversions were confirmed using a Kaiser test [43]. The resin was washed with DMF
and DCM before cleavage of the lipidated peptide construct from the resin was achieved using a
95:2.5:2.5 mixture of TFA:TIPS:water. The crude peptide was precipitated into cold diethyl ether,
collected by centrifugation, redissolved in 20% acetonitrile/water, and lyophilized.
4.4. Peptide Purification
All peptides were purified by reversed-phase HPLC using a Shimadzu system comprising two
LC-8A pumps and an SPD-10AVP UV-Vis detector. Lysine-rich peptides were purified on a Kinetix
Evo C18 column, and Glutamic-acid-rich peptides were purified using a Vydac protein C4 column.
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Eluents used were water containing 0.1% TFA (A) and MeCN with 0.1% TFA (B); all peptides were
eluted using a gradient of 20–90% B over 40 min at a flow rate of 15 mL min−1. The collected fractions
were examined using LCMS, (Table S1 and Figures S5–S12), and the fractions containing purified
peptide were pooled and freeze-dried.
4.5. Formation of Liposomes
One millimolar (1 mM) stock solutions containing DOPC:DOPE:cholesterol (50:25:25 mol %) or
DOPC:DOPE:cholesterol:DOPE-LR:DOPE-NBD (49.5:24.75:24.75:0.5:0.5 mol %) were prepared in a 1:1
(v/v) chloroform:MeOH solution. Stock solutions of the lipidated peptides were prepared at 50 µM
concentration in the same solvent system.
For the lipid-mixing assays, fluorescent liposomes containing K-lipopeptide constructs and
non-fluorescent E-lipopeptide-containing liposomes were prepared at 500 µM concentration with
1 mol % lipopeptide. Lipid films were formed by evaporating the chloroform:MeOH solution under a
stream of air and rehydrating the resulting film with PBS buffer. The solution was then sonicated at
55 ◦C for ~10 min to yield liposomes of ~100 nm diameter as assessed by dynamic light scattering (DLS)
spectroscopy on a Zetasizer Nano S (Malvern Instruments, Malvern, UK) using PMMA low-volume
cuvettes (VWR international, Leuven, Belgium) . After formulation, the solutions were diluted to
the working concentration of 100 µM. Examples of size distributions of liposomes can be found in
Figure S3.
For content-mixing assays, liposomes were prepared at 500 µM concentration with 1 mol %
lipopeptide. Liposomes functionalized with K-lipopeptides were rehydrated with PBS and prepared
in the same manner as liposomes used for lipid-mixing assays. Liposomes bearing E-lipopeptides
were rehydrated with PBS containing 20 mM sulforhodamine B. The solution was then sonicated
as before, and non-encapsulated sulforhodamine B was removed by passing the liposomes down a
Sephadex G25 column (GE healthcare, Eindhoven, The Netherlands). After size exclusion, liposomes
were diluted to the working concentration of 100 µM.
4.6. Fluorescence Spectroscopy
Lipid- and content-mixing assays were performed using a TECAN infinite M1000 PRO fluorimeter
at 25 ◦C. All experiments were performed in 96-well plates.
For the lipid-mixing experiments, fluorescence intensity was measured continuously for 1 h by
monitoring NBD emission at 530 nm after mixing equimolar amounts of E- and K-functionalised
liposomes. The percentage of lipid-mixing between the liposomes was calculated according to
Equation (1):
% lipid mixing = (F(t) − F0)/(Fmax − F0) (1)
where F(t) is the fluorescence intensity at time ‘t’, F0 is the baseline fluorescence value, which was
determined by measuring the fluorescence intensity of NBD-containing, K-functionalised liposomes to
which an equal amount of PBS had been added, and Fmax is the maximum fluorescence value, which
was obtained by measuring the fluorescence intensity from liposomes containing half the concentration
of fluorescent lipids (i.e., 0.25 mol % each of DOPE-LR and DOPE-NBD).
For content-mixing experiments, sulforhodamine B fluorescence intensity was measured for
60 min at 580 nm after mixing non-fluorescent K-liposomes with sulforhodamine B-containing
E-liposomes. Negative control liposomes were prepared from the E-liposomes mixed with an equal
number of plain liposomes. The percentage fluorescence increase was calculated using Equation (2):
% F = (F(t) − F0)/F0 (2)
where F0 is defined as the fluorescence of each sample directly after mixing of the liposomes.
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4.7. Tryptophan Fluorescence Experiments
Lipid films for the liposomes used in tryptophan fluorescence studies were prepared at a constant
peptide concentration of 2.5 µM with varying amounts of lipid stock (DOPC:DOPE:cholesterol
50:25:25 mol %, 1 M total concentration) to create samples with different lipid equivalents. Tryptophan
was excited at 280 nm with a 10 nm band gap, and fluorescence emission between 300 and 450 nm
was collected. Each sample was measured three times with a 1 min interval, and the three spectra
were averaged.
4.8. Size Increase Experiments
Change in liposome size and size distribution were followed by DLS. Samples were measured
every 5 min for 90 min at a constant temperature of 25 ◦C. For every time point, 10 measurements of 6 s
each were performed and their values averaged. Samples were prepared at 0.5 mM lipid concentration
with 1% substituted by the respective lipopeptide. The non-lipidated binding partner, one equivalent,
was added to the liposomes as a 100 µM solution.
4.9. CD Experiments
CD spectra were measured using a JASCO J-815 CD spectrometer fitted with a Peltier temperature
controller set to 25 ◦C. Samples were measured in quartz cuvettes with a 5 mm path length. Spectra
were recorded from 260 to 190 nm at 1 nm intervals with a 1 nm bandwidth. Mean residue molar
ellipticity, (θ), (deg cm2 dmol.res−1) was calculated according to Equation (3):
[θ] =
100 × (θ)obs
c × n × l (3)
where (θ)obs is the observed ellipticity in mdeg, c is the peptide concentration in mM, n is the number
of peptide bonds, and l is the path length of the cuvette in cm. Percentage helicity was calculated from
the residue molar ellipticity at 222 nm using the following Equation (4):
Fhelix = ((θ)222 − (θ)0)/((θ)max − (θ)0) (4)
With (θ)max as the maximum theoretical mean residue elipticity, defined as (θ)max = (θ)∞ (n − x)/n
for an n residue helix and x an arbitrary number of amino acids assumed not to participate in
helix formation (we use three in all calculations). (θ)∞ is defined as the theoretical helicity of an
infinite α-helix and is temperature-dependent, defined via (θ)∞ = (−44,000 + 250T), with T being the
temperature in ◦C. The minimum signal expected for a random peptide coil at 222 nm is given as (θ)0,
and is also temperature-dependent via the following relationship (θ)0 = 2220 − 53T [35].
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/19/1/211/s1.
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Abbreviations
CD Circular dichroism
DCM Dichloromethane
DIC Diisopropylcarbodiimide
DIPEA Diisopropylethylamine
DLS Dynamic light scattering
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DMF Dimethylformamide
DNA Deoxyribonucleic acid
DOPC 1,2-dioleoyl-sn-glycero-3-phosphocholine
DOPE 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine
DOPE-LR 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl)
DOPE-NBD 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2,1,3-benzoxadiazol-4-yl)
Fmoc Fluorenylmethyloxycarbonyl
FRET Fluorescence resonance energy transfer
HATU 1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid
hexafluorophosphate
HPLC High performance liquid chromatography
LUV Large unilamellar vesicle
MeCN Acetonitrile
MeOH Methanol
Mtt Methoxytrityl
NMR Nuclear magnetic resonance
PBS Phosphate buffered saline
PEG Polyethylene glycol
PNA Peptide nucleic acid
PMMA Poly(methyl methacrylate)
SEM Standard error of measurement
TIPS Triisopropylsilane
TFA Trifluoroacetic acid
TLC Thin-layer chromatography
Trp Tryptophan
SNARE soluble NSF (N-ethylmaleimide-sensitive factor) attachment protein receptor
UV-Vis Ultra violet-visible
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